Skip to main content
Signal8

Harsch Mutya

SEC insider (Form 3/4/5 filer). CIK 0001727809. CHIEF LEGAL OFFICER AND GC at VYNE Therapeutics Inc. (VYNE). 11 reported Form 4/5 transactions since Sep 2024; latest on Jul 23, 2026. Located in STEWARTSVILLE, NJ.

Companies Harsch Mutya has filed insider reports for

  • VYNE Therapeutics Inc. (VYNE): Officer, CHIEF LEGAL OFFICER AND GC
Harsch Mutya profile photo

Harsch Mutya

CIK: 0001727809

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (18.2%)

Compensation grants

Other (G, F, J, C, D, …)9 (81.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

VYNE Therapeutics Inc. logo
VYNE

VYNE Therapeutics Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (11 total)

  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Jul 23, 2026
    Tax Payment
    Direct
    22.5K shares at avg. $0.90$20K
  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Jun 30, 2026
    Tax Payment
    Direct
    3.5K shares at avg. $0.65$2K
  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Mar 31, 2026
    Tax Payment
    Direct
    4K shares at avg. $0.60$2K
  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Dec 31, 2025
    Tax Payment
    Direct
    3.6K shares at avg. $0.58$2K
  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Sep 30, 2025
    Tax Payment
    Direct
    3.6K shares at avg. $0.34$1K
  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Jun 30, 2025
    Tax Payment
    Direct
    3.6K shares at avg. $1.65$6K
  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Jun 2, 2025
    Award
    Direct
    1.1K shares at avg. $0.81$927.45
  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Mar 31, 2025
    Tax Payment
    Direct
    8.8K shares at avg. $1.58$14K
  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Jan 21, 2025
    Award

    Stock Option (right to buy)

    Direct
    230K shares-
  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Dec 31, 2024
    Tax Payment
    Direct
    4.7K shares at avg. $3.35$16K

1-10 of 11